A randomized double-blind phase II study comparing the efficacy, safety, and tolerability of combination antivirals (Amantadine, Ribavirin, Oseltamivir) versus Oseltamivir for the treatment of influenza in adults at risk for complications

Project no.: HIV-NAT 164/IRC003

This is a multicentered, randomized double-blind phase 2 study that will assess the efficacy, safety, and tolerability of combination antivirals (ribavirin, Tamiflu and amantadine) versus the standard treatment (Tamiflu) for the treatment of influenza in an at-risk outpatient population.